Alar Pharmaceuticals (Taiwan) Today
| 6785 Stock | TWD 160.00 8.50 5.61% |
Performance0 of 100
| Odds Of DistressLess than 37
|
Alar Pharmaceuticals is selling for under 160.00 as of the 30th of November 2024; that is 5.61% up since the beginning of the trading day. The stock's lowest day price was 150.5. Alar Pharmaceuticals has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Alar Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Alar Pharmaceuticals Inc. operates as a drug development company. The company was founded in 2016 and is based in Taichung, Taiwan. ALAR PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. The company has 57 M outstanding shares. More on Alar Pharmaceuticals
Moving together with Alar Stock
| 0.87 | 4114 | Synmosa Biopharma | PairCorr |
| 0.65 | 6576 | Foresee Pharmaceuticals | PairCorr |
| 0.87 | 6620 | Handa Pharmaceuticals | PairCorr |
| 0.78 | 6539 | DV Biomed | PairCorr |
Moving against Alar Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Alar Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alar Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alar Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Alar Pharmaceuticals (6785) is traded on Taiwan OTC Exchange in Taiwan and employs 19 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alar Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Alar Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alar Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 57 M outstanding shares.
Alar Pharmaceuticals has accumulated about 556.12 M in cash with (71.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.76.
Check Alar Pharmaceuticals Probability Of Bankruptcy
Alar Pharmaceuticals Risk Profiles
Although Alar Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Alar Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.18 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.25 | |||
| Risk Adjusted Performance | (0.07) |
Alar Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alar Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Tools for Alar Stock Analysis
When running Alar Pharmaceuticals' price analysis, check to measure Alar Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alar Pharmaceuticals is operating at the current time. Most of Alar Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alar Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alar Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alar Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.